Matches in Wikidata for { <http://www.wikidata.org/entity/Q65401036> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q65401036 description "clinical trial" @default.
- Q65401036 description "ensayu clínicu" @default.
- Q65401036 description "klinisch onderzoek" @default.
- Q65401036 description "клінічне випробування" @default.
- Q65401036 description "կլինիկական փորձարկում" @default.
- Q65401036 name "A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate" @default.
- Q65401036 name "A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate" @default.
- Q65401036 type Item @default.
- Q65401036 label "A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate" @default.
- Q65401036 label "A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate" @default.
- Q65401036 prefLabel "A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate" @default.
- Q65401036 prefLabel "A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate" @default.
- Q65401036 P1050 Q65401036-B12B34A0-7F82-4850-A1BA-FDE6C58CCB1D @default.
- Q65401036 P1132 Q65401036-9FF2E727-17B9-470C-A675-B694A8720DF3 @default.
- Q65401036 P1476 Q65401036-E7170298-D73A-4780-8E4B-36218A0C3557 @default.
- Q65401036 P17 Q65401036-8BF29803-CD7E-411F-8E91-9C35D8AF6054 @default.
- Q65401036 P17 Q65401036-E14AB1DE-9C45-444D-BD37-2DC27545C010 @default.
- Q65401036 P2899 Q65401036-4D4C45C7-DABF-40CB-88DE-BC6891106139 @default.
- Q65401036 P3098 Q65401036-46F2A6B3-0A16-46A4-96E7-189BD75D07DC @default.
- Q65401036 P31 Q65401036-29335A71-28E6-47A2-82F2-123B7EEAF55D @default.
- Q65401036 P4135 Q65401036-7D69F878-C91B-4A39-B732-C9A47B11327C @default.
- Q65401036 P580 Q65401036-5D96D087-A559-4543-B8B4-21238F87BF66 @default.
- Q65401036 P582 Q65401036-CE624EC6-65A2-484B-BCD8-6218BDAF0F68 @default.
- Q65401036 P6099 Q65401036-9289E2D6-61A8-47B2-94AA-1EE1A4AE1DCA @default.
- Q65401036 P8363 Q65401036-CAB31975-816E-4DE7-8B0C-2826539AC57C @default.
- Q65401036 P1050 Q170990 @default.
- Q65401036 P1132 "+30" @default.
- Q65401036 P1476 "A Phase 1, Randomized, Placebo-controlled, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate" @default.
- Q65401036 P17 Q30 @default.
- Q65401036 P17 Q36 @default.
- Q65401036 P2899 "+18" @default.
- Q65401036 P3098 "NCT02698657" @default.
- Q65401036 P31 Q30612 @default.
- Q65401036 P4135 "+65" @default.
- Q65401036 P580 "2016-02-23T00:00:00Z" @default.
- Q65401036 P582 "2017-09-07T00:00:00Z" @default.
- Q65401036 P6099 Q5452194 @default.
- Q65401036 P8363 Q78089383 @default.